Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Norgine
Norgine
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Feraccru
Ferric maltol
2016-02-18
2031-2035
Iron-deficiency anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ferric maltol
deficiency diseases
,
crohn disease
,
hypertension
,
pulmonary hypertension
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
ulcerative colitis
,
colitis
,
ulcer
,
colonic neoplasms
,
iron-deficiency anemia
,
iron deficiencies
,
anemia
,
inflammatory bowel diseases
,
intestinal diseases
,
heart failure
,
infertility
,
aneuploidy
,
chalazion
,
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma of lung
Fluorescein lisicol
pharmacokinetics
,
non-alcoholic fatty liver disease
,
fatty liver
,
hepatitis
,
hepatitis a
,
viral hepatitis human
,
liver diseases
,
liver cirrhosis
,
fibrosis
Ulimorelin
gastrointestinal diseases
,
digestive system diseases
,
healthy volunteers/patients
,
diabetes mellitus
,
gastroparesis
,
ileus
,
gastrointestinal motility
Nrl0706
colonic neoplasms
Movicol
constipation
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use